Evidence map›Paper›PMID 24726304›Full record

ArticleBioorganic & medicinal chemistry2014

Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents.

Bora Park, Divya Awasthi, Soumya R Chowdhury, Eduard H Melief, Kunal Kumar, Susan E Knudson, Richard A Slayden, Iwao Ojima

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Targeting the Bacterial Division Protein FtsZ.Journal of medicinal chemistry · 2016
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Bora ParkDepartment of Chemistry, Stony Brook University, Stony Brook, NY 11794-3400, United States.
Divya AwasthiDepartment of Chemistry, Stony Brook University, Stony Brook, NY 11794-3400, United States.
Soumya R ChowdhuryInstitute of Chemical Biology and Drug Discovery, Stony Brook University, Stony Brook, NY 11794-3400, United States.
Eduard H MeliefInstitute of Chemical Biology and Drug Discovery, Stony Brook University, Stony Brook, NY 11794-3400, United States.
Kunal KumarInstitute of Chemical Biology and Drug Discovery, Stony Brook University, Stony Brook, NY 11794-3400, United States.
Susan E KnudsonDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523-0922, United States.
Richard A SlaydenDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523-0922, United States.
Iwao OjimaInstitute of Chemical Biology and Drug Discovery, Stony Brook University, Stony Brook, NY 11794-3400, United States. Electronic address: iwao.ojima@stonybrook.edu.
Stony Brook University · USColorado State University · US

Funding

Novel Antimicrobials Targeting Cell DivisionR01AI078251 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI OJIMA, IWAO · 2009 to 2013
$1.9M
NIAID NIH HHS AI078251NIAID NIH HHS R01 AI078251PHS HHS U01082164
6 · The paper itself

Abstract

Filamenting temperature-sensitive protein Z (FtsZ), an essential cell division protein, is a promising target for the drug discovery of new-generation antibacterial agents against various bacterial pathogens. As a part of SAR studies on benzimidazoles, we have synthesized a library of 376 novel 2,5,6-trisubstituted benzimidazoles, bearing ether or thioether linkage at the 6-position. In a preliminary HTP screening against Mtb H37Rv, 108 compounds were identified as hits at a cut off concentration of 5 μg/mL. Among those hits, 10 compounds exhibited MIC values in the range of 0.63-12.5 μg/mL. Light scattering assay and TEM analysis with the most potent compound 5a clearly indicate that its molecular target is Mtb-FtsZ. Also, the Kd of 5a with Mtb-FtsZ was determined to be 1.32 μM.

Indexed as

Drug DesignAnimalsAntitubercular AgentsArchaeal ProteinsBenzimidazolesCell SurvivalChlorocebus aethiopsMicrobial Sensitivity TestsMycobacterium tuberculosisStructure-Activity RelationshipVero CellsAntitubercular AgentsArchaeal ProteinsBenzimidazolesFtsZ protein, Methanococcus jannaschiiAntibacterialBenzimidazoleFtsZTuberculosis

Identifiers

PMID24726304
PMCPMC4045703
OpenAlexW1994513825

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.